{"id":385768,"date":"2023-06-19T00:00:00","date_gmt":"2023-06-19T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041087-medtech-electrophysiology-mapping-and-ablation-devices-market-insights-asia-pacific-2024\/"},"modified":"2026-04-15T23:03:15","modified_gmt":"2026-04-15T23:03:15","slug":"47041087-medtech-electrophysiology-mapping-and-ablation-devices-market-insights-asia-pacific-2024","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041087-medtech-electrophysiology-mapping-and-ablation-devices-market-insights-asia-pacific-2024\/","title":{"rendered":"Electrophysiology Mapping and Ablation Devices | Market Insights | Asia Pacific | 2024"},"content":{"rendered":"<p>Although the global\u00a0COVID-19\u00a0pandemic negatively impacted the Asia Pacific\u00a0EP\u00a0mapping and ablation device market in 2020, the market has shown strong recovery and will resume prepandemic growth trends in the near term. Going forward, the Asia Pacific\u00a0EP\u00a0mapping and ablation device market will\u00a0expand rapidly,\u00a0supported by\u00a0rising\u00a0AF\u00a0treatment volumes, an expanding patient pool, improving access to healthcare, and the emergence of newer, premium-priced devices, although cost constraints and a challenging reimbursement environment will hinder the pace of market\u00a0expansion\u00a0to some extent.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for\u00a0EP\u00a0mapping and ablation devices in Asia Pacific from 2019 through 2032.<\/p>\n","protected":false},"template":"","class_list":["post-385768","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-electrophysiology-mapping-and-ablation-devices","medtech-geography-asia-pacific","medtech-date-976"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385768","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385768\/revisions"}],"predecessor-version":[{"id":387280,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385768\/revisions\/387280"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385768"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}